Gomes Heloisa Sousa, Corrêa-Faria Patrícia, Silva Tarcília Aparecida, Paiva Saul Martins, Costa Paulo Sérgio Sucasas, Batista Aline Carvalho, Costa Luciane Rezende
Universidade Federal de Goiás, Goiânia, GO, Brazil.
Departamento de Odontopediatria e Ortodontia, Faculdade de Odontologia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Braz Oral Res. 2015;29(1):S1806-83242015000100305. doi: 10.1590/1807-3107BOR-2015.vol29.0125. Epub 2015 Oct 9.
Little is known about whether midazolam sedation can reduce salivary cortisol levels and consequently influence children's behaviour during dental treatment. The aim of this study was to evaluate the effect of midazolam sedation on salivary cortisol and its correlation with children's behaviour during restorative dental treatment. Eighteen healthy children, aged two to five years, were randomly assigned to two dental treatment appointments, both with physical restraint: oral midazolam 1 mg/kg (MS) and placebo (PS). An observer assessed the children's behaviour (videos) using the Ohio State University Behavioral Rating Scale (OSUBRS). The children's saliva was collected just after waking up, on arrival at the dental school, 25 minutes after local anaesthesia, and 25 minutes after the end of the procedure. Salivary cortisol levels were determined using the enzyme-linked immunoabsorbent assay. The data were analysed by bivariate tests and multivariate analysis of variance (5% level). Salivary cortisol levels were lower in the MS group than in the PS group at the time of anaesthesia (p = 0.004), but did not vary during the appointment within sedation (p = 0.319) or placebo (p = 0.080) groups. Children's behaviour was negative most of the time and did not differ between MS and PS; however, the behaviour (OSUBRS) did not correlate with salivary cortisol levels. Oral midazolam is able to control salivary cortisol levels during dental treatment of pre-schoolers, which might not lead to better clinical behaviour.
关于咪达唑仑镇静是否能降低唾液皮质醇水平并进而影响儿童牙科治疗期间的行为,目前所知甚少。本研究的目的是评估咪达唑仑镇静对唾液皮质醇的影响及其与儿童修复性牙科治疗期间行为的相关性。18名年龄在2至5岁的健康儿童被随机分配到两次牙科治疗预约中,均采用身体约束:口服1mg/kg咪达唑仑(MS组)和安慰剂(PS组)。一名观察者使用俄亥俄州立大学行为评定量表(OSUBRS)评估儿童的行为(视频)。在儿童醒来后、到达牙科学院时、局部麻醉后25分钟以及治疗结束后25分钟采集唾液。使用酶联免疫吸附测定法测定唾液皮质醇水平。数据通过双变量检验和多变量方差分析(5%水平)进行分析。麻醉时,MS组的唾液皮质醇水平低于PS组(p = 0.004),但在镇静组(p = 0.319)或安慰剂组(p = 0.080)的预约过程中没有变化。儿童的行为在大多数时间为负面,MS组和PS组之间没有差异;然而,行为(OSUBRS)与唾液皮质醇水平无关。口服咪达唑仑能够在学龄前儿童牙科治疗期间控制唾液皮质醇水平,但这可能不会导致更好的临床行为表现。